Han Phan
Neurology with Special Qualifications in Child Neurology · Atlanta, GANPI 1306954037
Payments from drug & device makers
Across 1,447 payments — averaging $11,308 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sarepta Therapeutics, Inc.$6.5M
- Applied Therapeutics, Inc.$5.2M
- Takeda Pharmaceuticals U.S.A., Inc.$1.2M
- Ultragenyx Pharmaceutical Inc.$1M
- Biogen$562K
- PTC Therapeutics, Inc.$423K
- plus $1.5M from 23 others
Across 28 payments — averaging $1492.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$17K
- Eli Lilly$14K
- NS Pharma, Inc.$7K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$3K
- Teva Pharmaceuticals USA, Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sarepta Therapeutics, Inc. | 402 | $6,458,062 |
| Applied Therapeutics, Inc. | 440 | $5,216,904 |
| Takeda Pharmaceuticals U.S.A., Inc. | 132 | $1,187,130 |
| Ultragenyx Pharmaceutical Inc. | 123 | $1,010,664 |
| Biogen | 15 | $561,629 |
| PTC Therapeutics, Inc. | 62 | $423,393 |
| Harmony Biosciences LLC | 57 | $273,788 |
| Roche Products Limited | 11 | $155,118 |
| NS Pharma, Inc. | 35 | $144,205 |
| Vertex | 4 | $131,101 |
| Biohaven Pharmaceutical Holding Company Ltd. | 25 | $123,196 |
| Pfizer | 44 | $94,535 |
| ITF Therapeutics LLC | 6 | $80,861 |
| Hoffmann-la Roche Limited | 4 | $75,810 |
| Acadia Pharmaceuticals Inc | 2 | $64,500 |
| Mallinckrodt Enterprises LLC | 13 | $59,933 |
| Amgen | 4 | $52,471 |
| Eli Lilly | 8 | $48,626 |
| H. Lundbeck A S | 11 | $48,400 |
| Genentech, Inc. | 11 | $46,251 |
| Teva Pharmaceuticals USA, Inc. | 20 | $24,355 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 2 | $21,809 |
| UCB SA | 1 | $12,696 |
| GW Research Limited | 1 | $12,650 |
| Vanda Pharmaceuticals Inc. | 2 | $11,429 |
| Mallinckrodt Hospital Products Inc. | 5 | $8,651 |
| Genentech USA, Inc. | 3 | $7,315 |
| Jazz Pharmaceuticals Inc. | 2 | $7,237 |
| Insmed, Inc. | 2 | $88 |
How this compares
$16,362,807 in reported general payments places this provider in the 95th percentile of 41 neurology with special qualifications in child neurology providers in Georgia.
See all neurology with special qualifications in child neurology providers in Georgia →
Other neurology with special qualifications in child neurology in Atlanta
- Chaouki KhouryAtlanta$1M
- Stephanie KellerAtlanta$84K
- Guojun ZhangAtlanta$56K
- Raymond ChengAtlanta$40K
- Sonam BhallaAtlanta$23K
- Sumit VermaAtlanta$13K
- Cherise FrazierAtlanta$13K
- Howard SchubAtlanta$7K
- Ton de GrauwAtlanta$4K
- Jamika Hallman-CooperAtlanta$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.